Literature DB >> 17024519

Of porcupines and poodles--a joint challenge to industry and the profession.

Paul Hilton1.   

Abstract

Mesh：

Year:  2006        PMID： 17024519     DOI： 10.1007/s00192-006-0218-3

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


× No keyword cloud information.
  34 in total

1.  Evaluation of conflict of interest in economic analyses of new drugs used in oncology.

Authors:  M Friedberg; B Saffran; T J Stinson; W Nelson; C L Bennett
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

2.  Drug company sponsorship of education could be replaced at a fraction of its cost.

Authors:  Ray Moynihan
Journal:  BMJ       Date:  2003-05-31

Review 3.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

4.  Good publication practice for pharmaceutical companies.

Authors:  Elizabeth Wager; Elizabeth A Field; Leni Grossman
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580

5.  Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.

Authors:  Mohit Bhandari; Jason W Busse; Dianne Jackowski; Victor M Montori; Holger Schünemann; Sheila Sprague; Derek Mears; Emil H Schemitsch; Dianne Heels-Ansdell; P J Devereaux
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

Review 6.  Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials.

Authors:  Dean Fergusson; Steve Doucette; Kathleen Cranley Glass; Stan Shapiro; David Healy; Paul Hebert; Brian Hutton
Journal:  BMJ       Date:  2005-02-19

7.  European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications.

Authors:  Adam Jacobs; Elizabeth Wager
Journal:  Curr Med Res Opin       Date:  2005-02       Impact factor: 2.580

8.  Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.

Authors:  M M Chren; C S Landefeld
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

9.  A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial.

Authors:  C R Chapple; R Martinez-Garcia; L Selvaggi; P Toozs-Hobson; W Warnack; T Drogendijk; D M Wright; J Bolodeoku
Journal:  Eur Urol       Date:  2005-09       Impact factor: 20.096

10.  A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts.

Authors:  R V Gibbons; F J Landry; D L Blouch; D L Jones; F K Williams; C R Lucey; K Kroenke
Journal:  J Gen Intern Med       Date:  1998-03       Impact factor: 5.128
View more
  3 in total

1.  Urogynaecological research: current and future developments.

Authors:  Gunnar Lose
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-24

2.  Response to P. Hilton: of porcupines and poodles-a joint challenge to industry and the profession.

Authors:  Christopher Chapple
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-04-05

3.  Publication ethics: science at its best and always informative.

Authors:  Diaa E E Rizk
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.